Accurate and Rapid Detection of ABH I-VI Blood Antigens - A Microarray Assay is the Way to Go
Based on the carbohydrate portion of the precursor structure, ABH antigens are categorized as type A I-VI, type B I-VI, and type H I-V. Since ABH antigens are expressed differently in different cells and tissues, it is necessary to measure specific antibodies against the antigenic subtypes in specific grafts. At CD BioGlyco, we construct a Glycan Display Platform and provide ABH blood type I-VI antigen microarray assays for the presence and significant absence of donor-specific antibodies.
Preparation of type I-VI ABH glycan microarrays We prepare glycan couplers by subjecting A, B, and H antigens to a photochemical thiol-ene reaction as well as a coupling reaction. Then, we print the glycan couplers on solid-phase carriers after contactless printing using a microarray printer. The types of solid phase carriers we provide are
N-hydroxysuccinimide activated slides
Epoxy activated slides
Others…
In this procedure, we optimize spot morphology and antigen density based on ABH type I-VI antigens and unexpressed blood group antigens using monoclonal anti-A and antigen B antibodies.
Specific antibody detection methods and data analysis We attach glycan microarray slides to a slide module to which diluted plasma samples are added and incubated. Scanning by a microarray scanner combined with fluorochrome-labeled antibodies is performed after dilution. For example, we test both sample and control erythrocytes with reagent anti-A and anti-B antibodies to identify A and/or B antigens on the erythrocytes. Also, the reagent red blood cells are reverse grouped using the reagent red blood cells to determine the presence of anti-A and/or anti-B in the sample to be tested.
We also provide statistical analysis of all data for more comprehensive and accurate measurement results.
Fig.1 Schematic diagram of ABH-glycan microarray. (CD BioGlyco)
Publication
Technology: Molecular modeling techniques
Journal: Scientific Reports
IF: 4.6
Published: 2018
Results: Using molecular modeling techniques, the authors have researched the synthesis of active trisaccharides and disaccharides of ABO blood group antigens to study the binding specificity to various C-type lectin receptors using glycan microarrays. The results of binding preferences suggest that unique glycosylation on galactose and fucose motifs is critical for C-type lectin receptor binding and that these interactions occur in a Ca2+-dependent manner.
Applications
ABH blood type I-VI antigen microarray can be used to assist in exploring the possibility of organ transplantation in medical practice.
ABH blood type I-VI antigen microarray can be used to evaluate the compatibility between recipient serum and donor red blood cells and to research the interaction between red blood cell antigens and plasma antibodies.
The ABH blood type I-VI antigen microarray can be used to analyze information specific to all isotypes of ABO antibodies.
ABH blood type I-VI antigen microarray can be used to detect donor-specific antibodies.
Advantages
CD BioGlyco has a team of scientists and researchers specializing in ABH blood type I-VI antigen microarray construction to provide custom protocols and comprehensive data analysis based on client requirements.
CD BioGlyco utilizes state-of-the-art glycan microarray construction technology and methods to ensure the accuracy of ABH blood type I-VI antigen microarray testing.
CD BioGlyco has a strong glycan display platform to provide efficient, high-quality glycan display array technology. We have a professional R&D team to develop trustworthy research solutions for our clients. If you would like to inquire about glycan microarrays, please feel free to contact us.
References
Jeyakanthan, M.; et al. ABH-glycan microarray characterizes ABO subtype antibodies: fine specificity of immune tolerance after ABO-incompatible transplantation. American Journal of Transplantation. 2016, 16: 1548-1558.
Shanthamurthy, C.D.; et al. ABO antigens active tri- and disaccharides microarray to evaluate C-type lectin receptor binding preferences. Scientific Reports. 2018, 8: 6603.
This service is for Research Use Only, not intended for any clinical use.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.